Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Neoplasm Metastasis, Sarcoma, Ewing

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Ependymoma, Medulloblastoma, Recurrence

Pancreatic Cancer Metastatic

Neuroblastoma

Carcinoma, Hepatocellular

Solid Tumors

Locally Advanced Pancreatic Cancer

Biliary Tract Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Neuroblastoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Ependymoma, Medulloblastoma

Colonic Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Desmoplastic Small Round Cell Tumor

Pancreatic Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Rhabdomyosarcoma

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Lung Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Metastatic Small Intestinal Adenocarcinoma

Neuroblastoma

Colorectal Neoplasms

BRAF V600 Colorectal Cancer

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Biliary Cancer Metastatic

Clinical Trials

SCOTI

I-SPY

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

PANCREAS

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

MEMMAT

PASS-01

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

TRIPP-FFX

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

ERASE-CRC

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

CANTOR

ISG-TULIPS

PANC

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Pancreas

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

CEIL

VICTORIA

Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

GRACIE

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

OPTICAL-2

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line